The Coronavirus Vaccine Market is expected to grow at a -12.0 % CAGR during the forecast period for 2024-2034.
Coronavirus Disease (COVID-19) is caused by coronavirus. Coronavirus is a type of virus which causes respiratory illness in humans and can causes serious illness in geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). Out of the seven types of coronavirus, SARS-CoV-2 is the one which can cause severe diseases like Middle East respiratory syndrome (MERS) and sudden acute respiratory syndrome (SARS). Increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines, which will result in expansion of coronavirus vaccine market during the forecast period.
Major factors responsible for the growth of this market are fast adoption of advance technologies, growing number of corona patients, increasing healthcare expenditures, rising awareness about corona virus, and increasing efforts by the pharmaceutical companies for the development of covid-19 vaccines. Furthermore, increasing research investments for the R&D of covid-19 vaccines is anticipated to drive the market growth in future. However, high cost required for clinical trials and for validation of vaccines is restraining the growth of coronavirus vaccine market.
The Coronavirus Vaccine Market can be segmented on the basis of Infection Type, Vaccine Type, End-Users, and region. On the basis of Infection Type, the market can be divided into HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, and MERS-CoV. SARS-CoV segment is expected to dominate the market as this virus is the main reason of covid-19 outbreak. On the basis of Vaccine Type, the market can be segmented into Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, and S-Protein based coronavirus vaccine. In terms of End-Users, market is divided into Hospitals, Clinics, Research Institutes, and Others. On the basis of region, the market is segmented into the North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the coronavirus vaccine market in the coming future.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of -25.0 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Infection Type, By Vaccine Type, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax, Inc, Moderna, AstraZeneca, Pfizer, Johnson &Johnson, GlaxoSmithKline, Bharath Biotech, Serum Institute of India, Sinopharm, AnGes, AIVITABiomedical, CanSinoBio, eubiologics, Genexine, GreenLight Bioscience, Gennova, Heat Biologics, INOVIO, IIBR, medicago, Symvivo, Valneva, Zydus Cadila, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Coronavirus Vaccine Market Snapshot
Chapter 4. Global Coronavirus Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Clinical Trial/Pipeline Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Major Investment, Partnerships and Collaborations in COVID 19 Research
Chapter 5. Market Segmentation 1: By Infection Type, Estimates & Trend Analysis
5.1. By Infection Type, & Market Share, 2020 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Infection Type:
5.2.1. HCoV-229E
5.2.2. HCoV-OC43
5.2.3. SARS-CoV
5.2.4. New Haven CoV
5.2.5. HKU1-CoV
5.2.6. MERS-CoV
Chapter 6. Market Segmentation 2: By Vaccine Type Estimates & Trend Analysis
6.1. By Vaccine Type & Market Share, 2020 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Vaccine Type:
6.2.1. Protein subunit
6.2.2. Viral Vector (non-replicating)
6.2.3. DNA
6.2.4. Inactivated Virus
6.2.5. RNA
6.2.6. Viral Vector (replicating)
6.2.7. Virus Like Particle
6.2.8. Others
Chapter 7. Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2020& 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Research Institutes
7.2.4. Others
Chapter 8. Coronavirus Vaccine Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Infection Type, 2020-2030
8.1.2. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Vaccine Type, 2020-2030
8.1.3. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By End-Users, 2020-2030
8.1.4. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts by country, 2020-2030
8.2. Europe
8.2.1. Europe Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030
8.2.2. Europe Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030
8.2.3. Europe Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030
8.2.4. Europe Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030
8.3. Asia Pacific
8.3.1. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030
8.3.2. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030
8.3.3. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030
8.3.4. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030
8.4. Latin America
8.4.1. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)
8.4.2. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)
8.4.3. Latin America Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)
8.5.2. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)
8.5.3. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030
Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. I-Mab Biopharma
9.1.2. Medicago
9.1.3. Airway Therapeutics
9.1.4. Tiziana Life Sciences
9.1.5. Inovio Pharmaceuticals
9.1.6. Novavax, Inc
9.1.7. Moderna
9.1.8. AstraZeneca
9.1.9. Pfizer
9.1.10. Johnson &Johnson
9.1.11. GlaxoSmithKline
9.1.12. Bharath Biotech
9.1.13. Serum Institute of India
9.1.14. Sinopharm
9.1.15. AnGes
9.1.16. AIVITABiomedical
9.1.17. CanSinoBio
9.1.18. eubiologics
9.1.19. Genexine
9.1.20. GreenLight Bioscience
9.1.21. Gennova
9.1.22. Heat Biologics
9.1.23. INOVIO
9.1.24. IIBR
9.1.25. medicago
9.1.26. Symvivo
9.1.27. Valneva
9.1.28. Zydus Cadila
9.1.29. CODAGENIX Inc.
9.1.30. Other Prominent Player
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Infection Type
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Vaccine Type
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on End-Users
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region
North America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Europe coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Asia Pacific coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Latin America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Middle East & Africa coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Competitive Landscape
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
